cysteine and montelukast

cysteine has been researched along with montelukast in 48 studies

Research

Studies (48)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's23 (47.92)29.6817
2010's22 (45.83)24.3611
2020's3 (6.25)2.80

Authors

AuthorsStudies
Reiss, TF; Shingo, S; Zhang, J1
Fregonese, L; Rossi, GA; Sabatini, F; Silvestri, M1
Crimi, N; Mastruzzo, C; Pagano, C; Palermo, F; Pistorio, MP; Prosperini, G; Vancheri, C1
Andersen, L; Bouchelouche, K; Bouchelouche, P; Horn, T; Nordling, J1
Chapman, KR; Ferreira, IM; Gutierrez, C; Jardim, JR; Sandrini, A; Zamel, N1
Bibi, H; Eliraz, A; Madar, Z; Offer, S; Shoseyov, D1
Banderet, LE; Cymerman, A; Fulco, CS; Kaminsky, D; Muza, SR1
Haggart, K; Lee, DK; Lipworth, BJ; Robb, FM1
Abe, M; Hayashi, Y; Katsuragi, T; Murai, A; Sakata, N; Tanaka, K1
Alinovi, R; Baraldi, E; Carraro, S; Corradi, M; Pasquale, MF; Zacchello, F; Zanconato, S1
Bonville, CA; Domachowske, JB; Rosenberg, HF1
Fireman, E; Kivity, S; Sade, K; Schwartz, Y1
Barnes, PJ; Bush, A; Kharitonov, SA; Lex, C; Nicholson, AG; Payne, DN; Wilson, NM; Zacharasiewicz, A1
Bulut, Y; Deveci, F; Ilhan, N; Muz, MH; Turgut, T; Yekeler, H1
Ferland, C; Langlois, A; Laviolette, M; Tremblay, GM1
Hisatome, I; Igawa, G; Igawa, O; Kaetsu, Y; Matsubara, K; Matsuura, T; Shigemasa, C; Sugihara, S; Yamamoto, Y1
Parker, D; Pavord, I; Rice, L; Woodcock, A1
Leff, AR; Meliton, AY; Munoz, NM1
Abe, M; Akitake, Y; Fukunaga, J; Hosokawa, M; Murai, A; Takahashi, M1
Bramanti, P; Caminiti, R; Cuzzocrea, S; Di Paola, R; Genovese, T; Mazzon, E; Muià, C; Rossi, A; Sautebin, L1
Akamatsu, K; Hirano, T; Ichikawa, T; Ichinose, M; Koarai, A; Matsunaga, K; Minakata, Y; Sugiura, H; Yanagisawa, S1
Klanderman, B; Lima, J; Sylvia, J; Tantisira, KG; Weiss, ST1
Ikeda, Y; Imbe, S; Iwanaga, T; Muraki, M; Sato, R; Tohda, Y; Yamagata, S1
Neves, JS; Radke, AL; Weller, PF1
Dakhama, A; Gelfand, EW; Han, J; Jia, Y; Okamoto, M; Shiraishi, Y; Takeda, K1
Hunter, JC; Jia, Y; Jimenez, J; Lieber, G; McLeod, RL1
Câmara, NO; Hiyane, MI; Landgraf, MA; Landgraf, RG; Pacheco-Silva, A; Silva, RC1
Bunga, S; Israel, E; Kazani, S; Sadeh, J; Wechsler, ME1
Ewert, R; Felix, SB; Gläser, S; Gustavus, B; Koch, B; Kunkel, G; Noga, O; Schäper, C1
Cai, BL; Fang, SH; Huang, XQ; Lu, YB; Wang, XX; Wei, EQ; Yu, SY; Zhang, WP; Zhang, XY1
Li, CC; Zhang, WX1
Niimi, A1
He, Y; Lei, Y; Liu, XJ; Luo, F; Su, Q; Tang, X; Tian, C; Whitsett, JA; Wu, Q1
Fuchimoto, Y; Ikeda, G; Kanehiro, A; Kataoka, M; Koga, H; Kurimoto, E; Miyahara, N; Taniguchi, A; Tanimoto, M; Tanimoto, Y; Waseda, K1
Kohno, S; Matsuse, H1
Chelakkot-Govindalayathila, AL; D'Alessandro-Gabazza, CN; Fujisawa, T; Gabazza, EC; Harada, E; Hosoki, K; Kainuma, K; Nagao, M; Roeen, Z; Toda, M1
Ahsan, F; Gupta, N; Patel, B1
Jou, I; Kang, SJ; Park, JS; Park, SM; Seo, MK; Woo, HG1
Brugha, R; Dickson, I; Eldridge, S; Griffiths, CJ; Grigg, J; Holloway, JW; Koh, L; Nwokoro, C; Pandya, H; Price, D; Rutterford, C; Sanak, M; Turner, S; Vulliamy, T1
Asae, KH; Koizumi, Y; Kojima, Y; Nagase, H; Ohta, K; Ro, S; Sugimoto, N; Ujino, M; Yamashita, N1
Ba, L; Du, J; Liu, F; Liu, R; Liu, S; Liu, Y; Xian, J; Yu, L; Zhang, J; Zhou, J1
Chen, Y; Deng, B; Guo, R; Jiang, J; Jing, Z; Shi, Z1
Arnaud, C; Arnol, N; Bäck, M; Belaïdi, E; Gautier-Veyret, E; Lévy, P; Pépin, JL; Perrin, M; Stanke-Labesque, F; Tamisier, R1
Araújo, AC; Haeggström, JZ; Tang, X1
Arakawa, M; Hasegawa, T; Hayashi, M; Kikuchi, T; Kimura, Y; Koya, T; Saito, A; Takeuchi, H; Tsukioka, K; Ueno, H; Watanabe, S1
Kim, KS; Liu, W; Prakash, A; Zhang, C; Zhu, N1
Al-Azzam, N; Elsalem, L1
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K1

Reviews

6 review(s) available for cysteine and montelukast

ArticleYear
[Leukotriene and respiratory syncytial virus].
    Zhonghua er ke za zhi = Chinese journal of pediatrics, 2013, Volume: 51, Issue:2

    Topics: Acetates; Asthma; Bronchiolitis, Viral; Cyclopropanes; Cysteine; Humans; Infant; Infant, Newborn; Leukotriene Antagonists; Leukotrienes; Nasopharynx; Quinolines; Respiratory Syncytial Virus Infections; Risk Factors; Sulfides

2013
Cough, asthma, and cysteinyl-leukotrienes.
    Pulmonary pharmacology & therapeutics, 2013, Volume: 26, Issue:5

    Topics: Acetates; Animals; Anti-Asthmatic Agents; Anti-Inflammatory Agents; Antitussive Agents; Asthma; Cough; Cyclopropanes; Cysteine; Glucocorticoids; Humans; Leukotriene Antagonists; Leukotrienes; Quinolines; Sputum; Sulfides

2013
Leukotriene receptor antagonists pranlukast and montelukast for treating asthma.
    Expert opinion on pharmacotherapy, 2014, Volume: 15, Issue:3

    Topics: Acetates; Animals; Anti-Asthmatic Agents; Asthma; Chromones; Cyclopropanes; Cysteine; Humans; Leukotriene Antagonists; Leukotrienes; Quinolines; Sulfides

2014
Targeting cysteinyl-leukotrienes in abdominal aortic aneurysm.
    Prostaglandins & other lipid mediators, 2018, Volume: 139

    Topics: Acetates; Aortic Aneurysm, Abdominal; Arachidonate 5-Lipoxygenase; Arachidonic Acid; Blood Vessels; Cyclopropanes; Cysteine; Humans; Leukotriene Antagonists; Leukotrienes; Quinolines; Receptors, Leukotriene; Sulfides; Thrombosis

2018
Leukotriene D
    Life sciences, 2020, Nov-01, Volume: 260

    Topics: Acetates; Airway Remodeling; Animals; Anti-Asthmatic Agents; Asthma; Bronchial Hyperreactivity; Cyclopropanes; Cysteine; Gene Expression; Humans; Hypersensitivity; Indoles; Inflammation Mediators; Leukotriene Antagonists; Leukotriene D4; Leukotrienes; Phenylcarbamates; Quinolines; Receptors, Leukotriene; Sulfides; Sulfonamides; Tosyl Compounds

2020
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
    Drug discovery today, 2016, Volume: 21, Issue:4

    Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk

2016

Trials

11 trial(s) available for cysteine and montelukast

ArticleYear
Inhibitory effect of a leukotriene receptor antagonist (montelukast) on neurokinin A-induced bronchoconstriction.
    The Journal of allergy and clinical immunology, 2003, Volume: 111, Issue:4

    Topics: Acetates; Adult; Bronchoconstriction; Cross-Over Studies; Cyclopropanes; Cysteine; Double-Blind Method; Female; Forced Expiratory Volume; Humans; Leukotriene Antagonists; Leukotriene D4; Leukotrienes; Male; Methacholine Chloride; Neurokinin A; Quinolines; Sulfides

2003
Effect of montelukast on exhaled nitric oxide and nonvolatile markers of inflammation in mild asthma.
    Chest, 2003, Volume: 124, Issue:4

    Topics: Acetates; Adult; Anti-Asthmatic Agents; Asthma; Biomarkers; Breath Tests; Cross-Over Studies; Cyclopropanes; Cysteine; Double-Blind Method; Exhalation; Female; Forced Expiratory Volume; Humans; Hydrogen Peroxide; Inflammation Mediators; Leukotrienes; Male; Nitric Oxide; Peak Expiratory Flow Rate; Pneumonia; Quinolines; Severity of Illness Index; Sulfides

2003
Cysteinyl leukotriene blockade does not prevent acute mountain sickness.
    Aviation, space, and environmental medicine, 2004, Volume: 75, Issue:5

    Topics: Acetates; Administration, Oral; Adult; Altitude Sickness; Analysis of Variance; Chromatography, High Pressure Liquid; Cross-Over Studies; Cyclopropanes; Cysteine; Double-Blind Method; Enzyme-Linked Immunosorbent Assay; Female; Humans; Leukotriene Antagonists; Leukotrienes; Male; Prevalence; Quinolines; Severity of Illness Index; Statistics, Nonparametric; Sulfides; Treatment Outcome

2004
Montelukast protects against nasal lysine-aspirin challenge in patients with aspirin-induced asthma.
    The European respiratory journal, 2004, Volume: 24, Issue:2

    Topics: Acetates; Administration, Inhalation; Adult; Aspirin; Asthma; Confidence Intervals; Cross-Over Studies; Cyclopropanes; Cysteine; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Female; Humans; Leukotrienes; Lysine; Male; Middle Aged; Nasal Provocation Tests; Peak Expiratory Flow Rate; Quinolines; Reference Values; Reproducibility of Results; Spirometry; Sulfides

2004
Effect of montelukast on basophil releasability in patients with asthma.
    The Israel Medical Association journal : IMAJ, 2005, Volume: 7, Issue:12

    Topics: Acetates; Adult; Asthma; Basophils; Cyclopropanes; Cysteine; Female; Histamine; Humans; Immunologic Factors; Leukotriene Antagonists; Leukotrienes; Male; Quinolines; Sulfides

2005
Salmeterol plus fluticasone propionate versus fluticasone propionate plus montelukast: a randomised controlled trial investigating the effects on airway inflammation in asthma.
    Respiratory research, 2007, Sep-27, Volume: 8

    Topics: Acetates; Adrenergic beta-Agonists; Adult; Albuterol; Androstadienes; Anti-Asthmatic Agents; Asthma; Bronchial Hyperreactivity; Cyclopropanes; Cysteine; Double-Blind Method; Drug Combinations; Female; Fluticasone; Fluticasone-Salmeterol Drug Combination; Forced Expiratory Volume; Histamine; Humans; Interleukin-8; Leukotriene Antagonists; Leukotrienes; Lung; Male; Quinolines; Spirometry; Sputum; Sulfides; Time Factors; Treatment Outcome; United Kingdom

2007
Molecular mechanism of the additive effects of leukotriene modifier in asthmatic patients receiving steroid therapy.
    Allergology international : official journal of the Japanese Society of Allergology, 2009, Volume: 58, Issue:1

    Topics: Acetates; Administration, Inhalation; Adrenal Cortex Hormones; Adult; Asthma; Chemokine CCL5; Chromones; Cyclopropanes; Cysteine; Cytokines; Drug Synergism; Female; Forced Expiratory Volume; Humans; Leukotriene Antagonists; Leukotrienes; Male; Middle Aged; Quinolines; Sulfides

2009
5-lipoxygenase pharmacogenetics in asthma: overlap with Cys-leukotriene receptor antagonist loci.
    Pharmacogenetics and genomics, 2009, Volume: 19, Issue:3

    Topics: Acetates; Adult; Anti-Asthmatic Agents; Asthma; Cyclopropanes; Cysteine; Female; Forced Expiratory Volume; Genotype; Humans; Hydroxyurea; Leukotriene Antagonists; Lipoxygenase Inhibitors; Male; Middle Aged; Polymorphism, Single Nucleotide; Quinolines; Receptors, Leukotriene; Sulfides

2009
Cysteinyl leukotriene antagonism inhibits bronchoconstriction in response to hypertonic saline inhalation in asthma.
    Respiratory medicine, 2011, Volume: 105, Issue:5

    Topics: Acetates; Administration, Inhalation; Adolescent; Adult; Aged; Asthma; Bronchoconstriction; Cyclopropanes; Cysteine; Epidemiologic Methods; Female; Humans; Leukotriene Antagonists; Leukotrienes; Male; Middle Aged; Polymorphism, Genetic; Quinolines; Receptors, Leukotriene; Saline Solution, Hypertonic; Sulfides; Young Adult

2011
Anti-inflammatory properties of montelukast, a leukotriene receptor antagonist in patients with asthma and nasal polyposis.
    Journal of investigational allergology & clinical immunology, 2011, Volume: 21, Issue:1

    Topics: Acetates; Adult; Aged; Anti-Inflammatory Agents, Non-Steroidal; Asthma; Asthma, Aspirin-Induced; Cell Count; Cyclopropanes; Cysteine; Eosinophils; Female; Humans; Leukotriene Antagonists; Leukotrienes; Male; Middle Aged; Nasal Lavage Fluid; Nasal Polyps; Neurokinin A; Quinolines; Substance P; Sulfides; Treatment Outcome

2011
Intermittent montelukast in children aged 10 months to 5 years with wheeze (WAIT trial): a multicentre, randomised, placebo-controlled trial.
    The Lancet. Respiratory medicine, 2014, Volume: 2, Issue:10

    Topics: Acetates; Anti-Asthmatic Agents; Appointments and Schedules; Arachidonate 5-Lipoxygenase; Asthma; Child, Preschool; Cyclopropanes; Cysteine; Drug Administration Schedule; Female; Genotype; Humans; Infant; Leukotrienes; Male; Quinolines; Respiratory Sounds; Sulfides; Treatment Outcome

2014

Other Studies

31 other study(ies) available for cysteine and montelukast

ArticleYear
Correlation of airway obstruction and patient-reported endpoints in clinical studies.
    The European respiratory journal, 2001, Volume: 17, Issue:2

    Topics: Acetates; Adolescent; Adult; Aged; Aged, 80 and over; Anti-Asthmatic Agents; Asthma; Clinical Trials as Topic; Cyclopropanes; Cysteine; Endpoint Determination; Female; Follow-Up Studies; Forced Expiratory Volume; Humans; Leukotriene Antagonists; Leukotrienes; Male; Middle Aged; Peak Expiratory Flow Rate; Pulmonary Ventilation; Quinolines; Sulfides; Treatment Outcome

2001
Cysteinyl leukotrienes induce human eosinophil locomotion and adhesion molecule expression via a CysLT1 receptor-mediated mechanism.
    Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology, 2002, Volume: 32, Issue:5

    Topics: Acetates; Cell Adhesion Molecules; Cell Movement; Child; Cyclopropanes; Cysteine; Eosinophils; Humans; Leukotrienes; Quinolines; Sulfides

2002
The cysteinyl-leukotriene D4 induces cytosolic Ca2+ elevation and contraction of the human detrusor muscle.
    The Journal of urology, 2003, Volume: 170, Issue:2 Pt 1

    Topics: Acetates; Calcium; Cells, Cultured; Cyclopropanes; Cysteine; Cytosol; Dose-Response Relationship, Drug; Humans; In Vitro Techniques; Indoles; Leukotriene Antagonists; Leukotriene D4; Leukotrienes; Membrane Proteins; Muscle Contraction; Muscle, Smooth; Phenylcarbamates; Quinolines; Receptors, Leukotriene; Sarcoplasmic Reticulum; Sulfides; Sulfonamides; Tosyl Compounds; Urinary Bladder

2003
A leukotriene receptor antagonist modulates iNOS in the lung and in a leukotriene-free cell model.
    Nitric oxide : biology and chemistry, 2003, Volume: 9, Issue:1

    Topics: Acetates; Allergens; Animals; Anti-Inflammatory Agents, Non-Steroidal; Asthma; Bronchoalveolar Lavage Fluid; Cell Line; Cyclopropanes; Cysteine; Cytokines; Dexamethasone; Epithelial Cells; Immunohistochemistry; Leukotriene Antagonists; Leukotrienes; Lung; Male; Models, Animal; Nitric Oxide; Nitric Oxide Synthase; Nitric Oxide Synthase Type II; Quinolines; Rats; Rats, Inbred BN; Sulfides

2003
Comparison study between the mechanisms of allergic asthma amelioration by a cysteinyl-leukotriene type 1 receptor antagonist montelukast and methylprednisolone.
    The Journal of pharmacology and experimental therapeutics, 2005, Volume: 312, Issue:2

    Topics: Acetates; Airway Resistance; Animals; Anti-Asthmatic Agents; Anti-Inflammatory Agents; Asthma; Bile; Bronchoalveolar Lavage Fluid; Cyclopropanes; Cysteine; Hypersensitivity; In Vitro Techniques; Leukocyte Count; Leukotriene A4; Leukotriene Antagonists; Leukotrienes; Lung; Methylprednisolone; Quinolines; Rats; Rats, Inbred BN; Receptors, Leukotriene; Sulfides

2005
Exhaled breath condensate cysteinyl leukotrienes are increased in children with exercise-induced bronchoconstriction.
    The Journal of allergy and clinical immunology, 2005, Volume: 115, Issue:4

    Topics: Acetates; Adolescent; Ammonia; Asthma, Exercise-Induced; Biomarkers; Breath Tests; Bronchoconstriction; Child; Cyclopropanes; Cysteine; Exhalation; Forced Expiratory Volume; Humans; Leukotriene Antagonists; Leukotriene B4; Leukotrienes; Nitric Oxide; Quinolines; Respiratory Function Tests; Sulfides

2005
Ribavirin and cysteinyl leukotriene-1 receptor blockade as treatment for severe bronchiolitis.
    Antiviral research, 2006, Volume: 69, Issue:2

    Topics: Acetates; Animals; Antiviral Agents; Bronchiolitis, Viral; Cyclopropanes; Cysteine; Disease Models, Animal; Drug Therapy, Combination; Humans; Leukotriene Antagonists; Leukotrienes; Lung; Mice; Mice, Inbred C57BL; Murine pneumonia virus; Pneumovirus Infections; Quinolines; Ribavirin; Sulfides; Treatment Outcome; Virus Replication

2006
Exhaled breath condensate cysteinyl leukotrienes and airway remodeling in childhood asthma: a pilot study.
    Respiratory research, 2006, Apr-07, Volume: 7

    Topics: Acetates; Adolescent; Asthma; Basement Membrane; Bronchi; Child; Child, Preschool; Cyclopropanes; Cysteine; Exhalation; Female; Humans; Leukotrienes; Male; Pilot Projects; Quinolines; Sulfides

2006
The effects of low dose leukotriene receptor antagonist therapy on airway remodeling and cysteinyl leukotriene expression in a mouse asthma model.
    Experimental & molecular medicine, 2006, Apr-30, Volume: 38, Issue:2

    Topics: Acetates; Airway Obstruction; Animals; Anti-Asthmatic Agents; Asthma; Collagen; Cyclopropanes; Cysteine; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Evaluation, Preclinical; Goblet Cells; Hyperplasia; Hypertrophy; Leukotriene Antagonists; Leukotrienes; Lung; Mice; Mice, Inbred BALB C; Mucus; Muscle, Smooth; Pulmonary Fibrosis; Quinolines; Receptors, Leukotriene; Respiratory Mucosa; Sulfides

2006
Montelukast regulates eosinophil protease activity through a leukotriene-independent mechanism.
    The Journal of allergy and clinical immunology, 2006, Volume: 118, Issue:1

    Topics: Acetates; Adult; Arachidonic Acids; Cell Movement; Cyclopropanes; Cysteine; Enzyme Activation; Eosinophils; Female; Humans; Indoles; Leukotriene Antagonists; Leukotrienes; Male; Matrix Metalloproteinase 9; Quinolines; Receptors, Cell Surface; Receptors, Urokinase Plasminogen Activator; Sulfides; Urokinase-Type Plasminogen Activator

2006
Role of cysteinyl leukotrienes in the proliferation and the migration of murine vascular smooth muscle cells in vivo and in vitro.
    Cardiovascular research, 2007, Oct-01, Volume: 76, Issue:1

    Topics: Acetates; Animals; Anti-Bacterial Agents; Calcimycin; Cell Movement; Cell Proliferation; Cells, Cultured; Cyclopropanes; Cysteine; Femoral Artery; Leukotriene Antagonists; Leukotrienes; Lipopolysaccharides; Macrophages; Male; Mice; Mice, Inbred C57BL; Models, Animal; Muscle, Smooth, Vascular; Myocytes, Smooth Muscle; Neovascularization, Physiologic; Quinolines; Sulfides; Wound Healing

2007
Blockade of avidity and focal clustering of beta 2-integrin by cysteinyl leukotriene antagonism attenuates eosinophil adhesion.
    The Journal of allergy and clinical immunology, 2007, Volume: 120, Issue:6

    Topics: Acetates; Arachidonate 5-Lipoxygenase; Benzoquinones; CD11b Antigen; CD18 Antigens; Cell Adhesion; Cells, Cultured; Chemokine CCL11; Cyclopropanes; Cysteine; Eosinophils; Humans; Inflammation Mediators; Interleukin-5; Leukotriene Antagonists; Leukotriene B4; Leukotrienes; Lipoxygenase Inhibitors; Quinolines; Sulfides

2007
Comparative study to elucidate the mechanism underlying the difference in airway hyperresponsiveness between two mouse strains.
    International immunopharmacology, 2007, Dec-20, Volume: 7, Issue:14

    Topics: Acetates; Administration, Inhalation; Animals; Bronchial Provocation Tests; Bronchoalveolar Lavage Fluid; Cyclopropanes; Cysteine; Eosinophils; Immunoglobulin G; Leukotriene Antagonists; Leukotrienes; Macrophages; Methacholine Chloride; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Ovalbumin; Quinolines; Receptors, Leukotriene; Respiratory Hypersensitivity; Species Specificity; Sulfides

2007
Effects of zileuton and montelukast in mouse experimental spinal cord injury.
    British journal of pharmacology, 2008, Volume: 153, Issue:3

    Topics: Acetates; Animals; Apoptosis; Arachidonate 5-Lipoxygenase; Cyclooxygenase 2; Cyclopropanes; Cysteine; Dinoprostone; Disease Models, Animal; Gene Expression Regulation; Hydroxyurea; Inflammation; Leukotrienes; Lipoxygenase Inhibitors; Male; Mice; Neutrophil Infiltration; Quinolines; Recovery of Function; Spinal Cord Injuries; Sulfides; Tumor Necrosis Factor-alpha

2008
Inhaled montelukast inhibits cysteinyl-leukotriene-induced bronchoconstriction in ovalbumin-sensitized guinea-pigs: the potential as a new asthma medication.
    International immunopharmacology, 2009, Volume: 9, Issue:11

    Topics: Acetates; Administration, Inhalation; Animals; Asthma; Bronchial Hyperreactivity; Bronchoconstriction; Cyclopropanes; Cysteine; Disease Models, Animal; Guinea Pigs; Immunologic Factors; Leukotriene Antagonists; Leukotriene C4; Leukotriene D4; Leukotrienes; Lung; Male; Ovalbumin; Quinolines; Sulfides

2009
Cysteinyl leukotrienes acting via granule membrane-expressed receptors elicit secretion from within cell-free human eosinophil granules.
    The Journal of allergy and clinical immunology, 2010, Volume: 125, Issue:2

    Topics: Acetates; Blotting, Western; Cell Separation; Cell-Free System; Cyclopropanes; Cysteine; Eosinophil Cationic Protein; Eosinophils; Flow Cytometry; Humans; Leukotriene Antagonists; Leukotrienes; Quinolines; Receptors, Leukotriene; Secretory Vesicles; Sulfides

2010
Montelukast during primary infection prevents airway hyperresponsiveness and inflammation after reinfection with respiratory syncytial virus.
    American journal of respiratory and critical care medicine, 2010, Aug-15, Volume: 182, Issue:4

    Topics: Acetates; Animals; Animals, Newborn; Anti-Asthmatic Agents; Bronchiolitis, Viral; Bronchoalveolar Lavage Fluid; Cyclopropanes; Cysteine; Disease Models, Animal; Inflammation; Interferon-gamma; Leukotriene Antagonists; Leukotrienes; Mice; Mice, Inbred BALB C; Quinolines; Recurrence; Respiratory Hypersensitivity; Respiratory Syncytial Virus Infections; Respiratory Syncytial Viruses; Sulfides

2010
Concomitant activity of histamine and cysteinyl leukotrienes on porcine nasal mucosal vessels and nasal inflammation in the rat.
    Pharmacology, 2010, Volume: 85, Issue:5

    Topics: Acetates; Animals; Cyclopropanes; Cysteine; Dose-Response Relationship, Drug; Drug Synergism; Drug Therapy, Combination; Female; Histamine; Histamine H1 Antagonists, Non-Sedating; Hypersensitivity; In Vitro Techniques; Leukotriene Antagonists; Leukotriene D4; Leukotrienes; Loratadine; Male; Nasal Mucosa; Neutrophil Infiltration; Quinolines; Rats; Rats, Inbred BN; Rhinitis; Sulfides; Sus scrofa

2010
Leukotrienes produced in allergic lung inflammation activate alveolar macrophages.
    Cellular physiology and biochemistry : international journal of experimental cellular physiology, biochemistry, and pharmacology, 2010, Volume: 26, Issue:3

    Topics: Acetates; Allergens; Animals; Asthma; Cyclopropanes; Cysteine; Disease Models, Animal; Klebsiella pneumoniae; Leukotriene Antagonists; Leukotriene C4; Leukotrienes; Lung; Macrophages, Alveolar; Male; Nitric Oxide; Ovalbumin; Phagocytosis; Pneumonia; Quinolines; Rats; Rats, Wistar; Receptors, IgG; Sulfides

2010
[Effects of agonist and antagonist of cysteinyl leukotriene receptors on differentiation of rat glioma C6 cells].
    Zhejiang da xue xue bao. Yi xue ban = Journal of Zhejiang University. Medical sciences, 2011, Volume: 40, Issue:2

    Topics: Acetates; Animals; Cell Differentiation; Cell Line, Tumor; Colforsin; Cyclopropanes; Cysteine; Glioma; Leukotriene Antagonists; Leukotriene D4; Leukotrienes; Quinolines; Rats; Receptors, Leukotriene; Sulfides

2011
Foxa2 regulates leukotrienes to inhibit Th2-mediated pulmonary inflammation.
    American journal of respiratory cell and molecular biology, 2013, Volume: 49, Issue:6

    Topics: Acetates; Animals; Arachidonate 12-Lipoxygenase; Arachidonate 15-Lipoxygenase; Arachidonate 5-Lipoxygenase; Cyclopropanes; Cysteine; Disease Models, Animal; Eosinophils; Goblet Cells; Hepatocyte Nuclear Factor 3-beta; Inflammation Mediators; Leukotriene Antagonists; Leukotrienes; Metaplasia; Mice; Mice, Knockout; Mice, Transgenic; Pneumonia; Quinolines; Signal Transduction; Sulfides; Th2 Cells

2013
Effect of a cysteinyl leukotriene receptor antagonist on experimental emphysema and asthma combined with emphysema.
    American journal of respiratory cell and molecular biology, 2014, Volume: 50, Issue:1

    Topics: Acetates; Animals; Asthma; Bronchoalveolar Lavage Fluid; Chemokines; Cyclopropanes; Cysteine; Female; Leukotriene Antagonists; Leukotrienes; Lung; Mice; Mice, Inbred BALB C; Pneumonia; Pulmonary Emphysema; Quinolines; Receptors, Leukotriene; Sulfides; Tumor Necrosis Factor-alpha

2014
Montelukast suppresses epithelial to mesenchymal transition of bronchial epithelial cells induced by eosinophils.
    Biochemical and biophysical research communications, 2014, Jul-04, Volume: 449, Issue:3

    Topics: Acetates; Airway Remodeling; Asthma; Bronchi; Cell Line, Tumor; Coculture Techniques; Collagen Type I; Cyclopropanes; Cysteine; Eosinophils; Epithelial-Mesenchymal Transition; Humans; Leukotriene Antagonists; Leukotrienes; Phosphorylation; Quinolines; Respiratory Mucosa; Smad3 Protein; Sulfides; Transforming Growth Factor beta1; Vimentin

2014
Aerosolized montelukast polymeric particles-an alternative to oral montelukast-alleviate symptoms of asthma in a rodent model.
    Pharmaceutical research, 2014, Volume: 31, Issue:11

    Topics: Acetates; Aerosols; Animals; Anti-Asthmatic Agents; Anti-Inflammatory Agents; Asthma; Bronchoalveolar Lavage Fluid; Cyclopropanes; Cysteine; Disease Models, Animal; Inflammation; L-Lactate Dehydrogenase; Lactic Acid; Leukotrienes; Lung; Ovalbumin; Peroxidase; Polyesters; Polymers; Quinolines; Rats; Rats, Sprague-Dawley; Sulfides

2014
Role of cysteinyl leukotriene signaling in a mouse model of noise-induced cochlear injury.
    Proceedings of the National Academy of Sciences of the United States of America, 2014, Jul-08, Volume: 111, Issue:27

    Topics: Acetates; Animals; Cochlea; Cyclopropanes; Cysteine; Disease Models, Animal; Gene Expression Profiling; Leukotriene Antagonists; Leukotrienes; Matrix Metalloproteinase 3; Mice; Noise; Quinolines; Receptors, Leukotriene; Signal Transduction; Sulfides; Wounds and Injuries

2014
Leukotriene receptor antagonist attenuated airway inflammation and hyperresponsiveness in a double-stranded RNA-induced asthma exacerbation model.
    Allergology international : official journal of the Japanese Society of Allergology, 2017, Volume: 66S

    Topics: Acetates; Alum Compounds; Animals; Anti-Asthmatic Agents; Asthma; Bronchoalveolar Lavage Fluid; Cyclopropanes; Cysteine; Cytokines; Disease Models, Animal; Disease Progression; Eosinophils; Immunization; Inflammation Mediators; Leukotriene Antagonists; Leukotrienes; Male; Mice; Ovalbumin; Poly I-C; Quinolines; Respiratory Hypersensitivity; RNA, Double-Stranded; RNA, Viral; Sulfides

2017
The role of cysteinyl leukotrienes and their receptors in refractory nasal polyps.
    Prostaglandins, leukotrienes, and essential fatty acids, 2017, Volume: 126

    Topics: Acetates; Adult; Cyclopropanes; Cysteine; Cytokines; Enterotoxins; Female; Gene Expression Regulation; Humans; Leukotriene Antagonists; Leukotrienes; Male; Middle Aged; Nasal Polyps; Quinolines; Receptors, Leukotriene; Sinusitis; Sulfides

2017
Cysteinyl leukotriene receptor 1 regulates glucose-stimulated insulin secretion (GSIS).
    Cellular signalling, 2018, Volume: 46

    Topics: Acetates; ADP-Ribosylation Factor 6; ADP-Ribosylation Factors; Animals; cdc42 GTP-Binding Protein; Cell Line, Tumor; Cyclopropanes; Cysteine; Diabetes Mellitus, Type 2; Glucose; Insulin Secretion; Insulin-Secreting Cells; Leukotrienes; Mice; Neuropeptides; Quinolines; rac1 GTP-Binding Protein; Receptors, Leukotriene; Sulfides

2018
Cysteinyl-leukotriene pathway as a new therapeutic target for the treatment of atherosclerosis related to obstructive sleep apnea syndrome.
    Pharmacological research, 2018, Volume: 134

    Topics: 5-Lipoxygenase-Activating Proteins; Acetates; Adult; Animals; Arachidonate 5-Lipoxygenase; Atherosclerosis; Case-Control Studies; Cyclopropanes; Cysteine; Disease Models, Animal; Disease Progression; Female; Humans; Leukotriene Antagonists; Leukotriene E4; Leukotrienes; Male; Mice, Knockout, ApoE; Middle Aged; Plaque, Atherosclerotic; Quinolines; Receptors, Leukotriene; Risk Factors; Signal Transduction; Sleep Apnea, Obstructive; Sulfides

2018
Cysteinyl Leukotriene Synthesis via Phospholipase A2 Group IV Mediates Exercise-induced Bronchoconstriction and Airway Remodeling.
    American journal of respiratory cell and molecular biology, 2020, Volume: 63, Issue:1

    Topics: Acetates; Airway Remodeling; Animals; Asthma; Bronchial Hyperreactivity; Bronchoconstriction; Cyclopropanes; Cysteine; Female; Group II Phospholipases A2; Leukotrienes; Lung; Methacholine Chloride; Mice; Mice, Inbred BALB C; Physical Conditioning, Animal; Quinolines; Respiratory Hypersensitivity; Sulfides

2020
Targeting E. coli invasion of the blood-brain barrier for investigating the pathogenesis and therapeutic development of E. coli meningitis.
    Cellular microbiology, 2020, Volume: 22, Issue:10

    Topics: Acetates; Animals; Anti-Bacterial Agents; Blood-Brain Barrier; Brain; Ceftriaxone; Cells, Cultured; Cyclopropanes; Cysteine; Drug Therapy, Combination; Endothelial Cells; ErbB Receptors; Escherichia coli; Female; Gefitinib; Humans; Infant, Newborn; Leukotriene Antagonists; Leukotrienes; Male; Meningitis, Escherichia coli; Mice; Permeability; Phospholipases A2, Cytosolic; Quinolines; Sphingosine-1-Phosphate Receptors; Sulfides

2020